US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.72

+0.03960.04%

Volume:4K

Turnover:352.32K

Market Cap:428.44M

PE:55.05

High:98.72

Open:97.85

Low:97.85

Close:98.68

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:0.08

T/O Rate:0.08%

Dividend:1.55

Dividend Rate:1.57%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.73

PE(LYR):5.29

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Correction: Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi

MT Newswires Live

Stoke Therapeutics, Biogen present long-term data on Zorevunersen

Stoke Therapeutics, Biogen Report 4-Year Open-Label Data for Dravet Drug Zorevunersen Showing Durable Seizure Reduction

Stoke Therapeutics and Biogen Present Long-Term Clinical Data That Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/PBE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":98.7191,"timestamp":1788465600000,"preClose":98.6795,"halted":0,"volume":3583,"delay":0,"changeRate":0.0004012991553462773,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":0.0396,"latestTime":"09-04 04:57:06 EDT","open":97.845,"high":98.7191,"low":97.845,"amount":352320.00883,"amplitude":0.008858,"askPrice":156.96,"askSize":100,"bidPrice":39.69,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":98.7191,"sharesOutstanding":3180000,"nav":98.70319,"aum":428371844.6,"dividendRate":0.01567,"bidAskSpread":0.001841,"postHourTrading":{"tag":"盘后","latestPrice":98.2701,"preClose":98.7191,"latestTime":"19:30 EDT","volume":11,"amount":1085.5828,"timestamp":1788478205255,"change":-0.449,"changeRate":-0.004548,"amplitude":0},"volumeRatio":0.08044743387138648,"impliedVol":0.1419,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.08044743387138648,"shares":4340000,"dividePrice":1.5469,"high":98.7191,"amplitude":0.008858,"preClose":98.6795,"low":97.845,"week52Low":67.69,"pbRate":"1.73","psRate":"249.58","week52High":98.82,"institutionHeld":0.2552,"latestPrice":98.7191,"eps":1.793292,"divideRate":0.01567,"volume":3583,"delay":0,"ttmEps":1.793292,"open":97.845,"prevYearClose":82.15,"prevWeekClose":96.32,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":98.54,"twentyDayClose":91.12,"sixtyDayClose":84.2484},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664138186","title":"Correction: Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138186","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138186?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:52","pubTimestamp":1788501121,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration  approved Eisai  and Biogen's subcutaneous autoinjector version of anti-amyloid beta protofibril antibody Leqembi as an initiation treatment for mild cognitive impairment due to Alzheimer's disease or mild AD dementia.The self-administered autoinjector is given once weekly at 500 mg through two 250 mg injections, according to a joint release on Thursday.The approval adds at-home subcutaneous treatment to the existing every-two-week intravenous regimen, with patients able to switch between the two administration methods during treatment, the release said.The product will be launched during Eisai's fiscal 2026, ending March 31, 2027.Shares of Eisai rose nearly 2% at market close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4532","BK4585","LU0320765992.SGD","IE00B19Z9Z06.USD","BK4139","BK4533","PBE","BIIB","LU0109394709.USD","LU0889565916.HKD","IE00B894F039.SGD","IE00B19Z9P08.USD","BMED","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807150","title":"Stoke Therapeutics, Biogen present long-term data on Zorevunersen","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807150?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:40","pubTimestamp":1788478812,"startTime":"0","endTime":"0","summary":"“Stoke Therapeutics (STOK) and Biogen Inc. (BIIB) announced presentations of data at the 16th European Epilepsy Congress taking place September 5-9...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/stoke-therapeutics-biogen-present-long-term-data-on-zorevunersen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/stoke-therapeutics-biogen-present-long-term-data-on-zorevunersen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIIB","LU0234570918.USD","PBE","LU0889565916.HKD","BK4007","BK4139","IE00B894F039.SGD","BMED","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BK4588","LU0109394709.USD","LENZ","EPV","BK4539","BK4532","BK4533","BK4585","LU0320765992.SGD","STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807353","title":"Stoke Therapeutics, Biogen Report 4-Year Open-Label Data for Dravet Drug Zorevunersen Showing Durable Seizure Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807353","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807353?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:30","pubTimestamp":1788478227,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics, Biogen report 4-year open-label data for Dravet drug zorevunersen showing durable seizure reductionStoke Therapeutics, Biogen flagged long-term zorevunersen data for Dravet syndrom","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLCgQYh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0234570918.USD","LU0320765992.SGD","PBE","BK4139","LU0889565916.HKD","BK4585","BK4532","BK4588","IE00B894F039.SGD","STOK","IE00B19Z9P08.USD","BIIB","BMED","IE00B19Z9Z06.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380733","title":"Stoke Therapeutics and Biogen Present Long-Term Clinical Data That Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664380733?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:30","pubTimestamp":1788478200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA8DKTRL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMED","BK4139","PBE","BIIB","BK4532","LU0320765992.SGD","IE00B894F039.SGD","LU0234570918.USD","BK4533","IE00B19Z9P08.USD","STOK","BK4585","BK4588","LU0109394709.USD","LU0889565916.HKD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBE\",params:#limit:6,delay:false,,,undefined,":[]}}